← Mechanisms of action
FLT1
SINGLE PROTEINHomo sapiens
Preferred name: Vascular endothelial growth factor receptor 1 ChEMBL ↗
Linked proteins
Drugs acting on this target (47)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| oql011 | Activator | experimental | Small molecule | FLT1 activator |
| Cambiogenplasmid (neovasculgen) | Agonist | experimental | Gene therapy | FLT1 agonist |
| icrucumab | Antagonist | experimental | mAb | FLT1 antagonist |
| ttac-0001 | Antagonist | experimental | Small molecule | FLT1 antagonist |
| cbp-4888 | Antisense inhibitor | experimental | Nucleic acid | FLT1 antisense inhibitor |
| 89zr-bevacizumab | Binding agent | experimental | mAb | FLT1 binding agent |
| vegfr1 | Immunity, active | experimental | Vaccine | FLT1 immunity, active |
| vegfr1-1084 | Immunity, active | experimental | Vaccine | FLT1 immunity, active |
| vegfr1-a24-1084 | Immunity, active | experimental | Vaccine | FLT1 immunity, active |
| 3d011-08 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| Acrizanib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| aee-788 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| aiv007 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| al8326 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| alflutinib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| anrotenib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| aur109 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| azd3759 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| bt01001 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| cbt-004 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| cm082 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| d-4517.2 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| eg-znmp-01 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| esk981 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| eyp-1901 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| famitinib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| glesatinib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| hb002.1m | Inhibitor | experimental | Recombinant protein | FLT1 inhibitor |
| hb0025 | Inhibitor | experimental | mAb | FLT1 inhibitor |
| icrucumab | Inhibitor | experimental | mAb | FLT1 inhibitor |
| migaldendranib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| nindetanib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| ningetinib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| odm 203 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| odm-203 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| pan-90806 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| rpi.4610 | Inhibitor | experimental | Recombinant protein | FLT1 inhibitor |
| subutinib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| sunitinib (sutent) | Inhibitor | approved | Small molecule | Vascular endothelial growth factor receptor 1 inhibitor |
| surufatinib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| syha1813 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| tavo412 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| tg-100801 | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| Tinengotinib | Inhibitor | experimental | Small molecule | FLT1 inhibitor |
| vegf receptor-fc fusion protein | Inhibitor | experimental | Botanical | FLT1 inhibitor |
| aav2-sflt01 | Supplementation | experimental | Gene therapy | FLT1 supplementation |
| raav.sflt-1 | Supplementation | experimental | Gene therapy | FLT1 supplementation |